Archives
-
Amikacin (BAY416651) in Resistance Research
2026-10-01
Amikacin (BAY416651) offers a practical orthogonal readout for bacterial protein synthesis inhibition, enzyme-mediated resistance, and comparative susceptibility workflows. This guide translates carbapenem-resistant Enterobacter cloacae transmission findings into reproducible assay design, stock preparation, gene-localization controls, and troubleshooting strategies.
-
Gap19: Hemichannel Selectivity in Ischemia
2026-09-30
Gap19 is a selective connexin 43 hemichannel blocker for separating Cx43 pore activity from broader inflammatory signaling. This article connects astrocyte ATP release, macrophage assay design, and neuroprotection in cerebral ischemia while defining the limits of current evidence.
-
Estradiol Assays: Linking Receptors to Organ Protection
2026-09-29
Explore how Estradiol and 17 beta-estradiol connect estrogen receptor signaling with autophagy, mitochondrial defense, and multi-organ protection. This guide translates recent human and mouse evidence into practical assay design, controls, and interpretation strategies.
-
Sulfachloropyridazine and Cecal Microbiota in Coccidiosis
2026-09-29
The reference study integrates 16S rRNA gene sequencing with LC-MS/MS metabolomics to define how ethanamizuril, Sulfachloropyridazine, and their combination affect chickens infected with Eimeria tenella. Its main contribution is to connect anticoccidial treatment with drug-specific microbial and metabolic changes, while showing that low-dose combination treatment caused limited additional disturbance.
-
NETs in CML and TKI-Associated Vascular Risk
2026-09-28
The reference study identifies increased neutrophil extracellular trap formation as a measurable feature of chronic myeloid leukemia and shows that tyrosine kinase inhibitors do not affect this process uniformly. Its human-sample, pharmacologic, and BCR-ABL1-transduced cell-model experiments provide a mechanistic framework for studying how treatment-related NET biology may contribute to vascular complications.
-
Weight Loss Restores Intestinal Stretch Satiety
2026-09-28
The study finds that intestinal stretch can acutely suppress feeding and improve oral glucose tolerance, while diet-induced obesity weakens these responses. Weight loss through dietary intervention or vertical sleeve gastrectomy restores stretch-associated satiety and nucleus of the solitary tract activation, supporting a gut–brain pathway distinct from the tested GLP-1 mechanisms.
-
HotStart Universal 2X Green qPCR Master Mix in ICC
2026-09-27
Translate FGFR2-fusion and asparagine-response biology in intrahepatic cholangiocarcinoma into a practical gene-expression workflow. The mix combines hot-start specificity with Green I fluorescence and a built-in ROX reference dye, while melt curves help distinguish the intended amplicon from nonspecific products.
-
ALC-0315: Practical LNP Formulation Guide
2026-09-26
ALC-0315 is an ionizable amino lipid for researchers assembling lipid nanoparticles for mRNA and other nucleic acid drug delivery workflows. It is intended as an LNP component dissolved in a compatible organic solvent, not as a water-soluble reagent or a stand-alone delivery system.
-
Bazedoxifene and IL-6/GP130 Signaling in Cancer
2026-09-26
Shi and colleagues review evidence that Bazedoxifene, an established selective estrogen receptor modulator, may also inhibit the IL-6/GP130 interaction and downstream signaling relevant to cancer progression. The review frames this as a preclinical repurposing opportunity—not an established cancer treatment—and highlights experiments needed to test target engagement, efficacy, and combination effects.
-
5-Methyl-CTP in mRNA Synthesis and Vaccine Workflows
2026-09-25
Use 5-Methyl-CTP to test whether a methylated cytidine substrate improves the stability and expression of your in vitro transcribed mRNA. A practical workflow connects nucleotide screening with the separate delivery challenge highlighted by a personalized tumor-vaccine study—while making clear that this chemistry was not tested in that study.
-
HyperScript RT SuperMix for qPCR in Senescence Studies
2026-09-25
Explore how HyperScript RT SuperMix for qPCR can support pathway-focused gene expression analysis in colorectal cancer senescence research. A recent study of I3C, UNC5B, and Wnt/β-catenin illustrates why careful cDNA preparation must be paired with causal controls and phenotypic validation.
-
JC-1 Workflows for Mitochondrial Membrane Potential
2026-09-24
Use JC-1 to track mitochondrial polarization while testing how treatments affect cell stress and death. This practical guide links assay setup and troubleshooting to pulmonary fibrosis research, while clarifying what the dye can—and cannot—say about ferroptosis.
-
Murine RNase Inhibitor: Practical RNA Workflow Guide
2026-09-24
Protect RNA in RT-PCR, cDNA synthesis, transcription, and labeling workflows with an inhibitor designed for pancreatic-type RNases. Its oxidative stability is especially useful when a protocol calls for low DTT, while its specificity makes it important to match the inhibitor to the RNase activity you need to control.
-
Gut-Brain Cholinergic Signaling in Seizure Control
2026-09-23
Jia et al. identify a gut–vagus–brain cholinergic circuit through which Bacteroides fragilis suppresses seizures in mouse models and improves outcomes in a randomized trial of pediatric refractory epilepsy. The study connects microbial composition, colonic ChAT-positive cells, vagal transmission, and seizure regulation while highlighting important limits for translating animal mechanisms to patients.
-
JAK Inhibitors and Endothelial Vascular Effects
2026-09-22
This comparative endothelial-cell study shows that approved JAK inhibitors can suppress cytokine release without uniformly correcting adhesion, coagulation, or cell-survival abnormalities. Its concentration- and inhibitor-dependent results help separate anti-inflammatory activity from vascular safety signals in inflammatory disease research.